OrthoView showcases version 5.2

TriMed Staff | | Health Imaging | Artificial Intelligence
OrthoView demonstrated its upgraded web-deployed version 5.2 software, an improved version of its orthopedic digital planning and templating software, at the recent 2008 RSNA conference in Chicago.

OrthoView 5.2 is available via PACS providers and offers a quicker start up time and an improved integration as well as added clinical features and additional template-handling capabilities, the company said.

OrthoView 5.2 contains a number of new clinical features in addition to improving overall performance that include new tools for the Spine module such as the Nash Moe Grading Guide; Thoracic Trunk Shift Wizard; a combined Pelvic Incidence, Sacral Slope and Pelvic Tilt Wizard, according to OrthoView.

TriMed Staff

Related Content

Could synthetic images replace the need for contrast?
Experts developing AI model that learns from calcium-scoring CT scans
FDA has approved over 1,000 clinical AI applications, with most aimed at radiology
Commercially available AI increases breast cancer detection by nearly 20%
Clinicians want AI to show its work
ACR Assess-AI national data registry tracks performance of clinical algorithms

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.